Puissance Capital Management LP's Net Worth
$112 Thousand
Who is Puissance Capital Management LP?
Puissance Capital Management LP does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ViewRay, Inc., Bellerophon Therapeutics, Inc., Tracon Pharmaceuticals, Inc., and EKSO BIONICS HOLDINGS, INC..
SEC CIK
Puissance Capital Management LP's CIK is 0001658437
Past Insider Trading and Trends
2023 was Puissance Capital Management LP's most active year for disposing of shares, totalling 1 transactions. Puissance Capital Management LP's most active month to dispose stocks was the month of September. In 2023 Puissance Capital Management LP cashed out on 1,076,841 shares for a total of $111,776.10, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
ViewRay, Inc. (VRAYQ) Snapshot price: $0.000001
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bellerophon Therapeutics, Inc. (BLPH) Snapshot price: $0.036
InvestorPuissance Capital Management LP used to own units in Common Stock but no longer holds any shares there. From 2018 to 2020 Puissance Capital Management LP disposed a total of 1,076,841 shares of Bellerophon Therapeutics, Inc. equalling to $111,776.10.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -1.08M |
$0.10 | -$111,776.10 |
0
|
Oct 13
| |||
Form 4
| -11.10% | -134.42K |
$0.83 | -$111,569.43 | 1.08M |
Jun 7
| |||
Form 4
| -31.62% | -560.00K |
$9.46 | -$5,297,600.00 | 1.21M |
May 18
| |||
Form 4
| +0.46% | 8.19K |
$4.00 | $32,756.00 | 1.77M |
Jun 7
| |||
Form 4
| +52.80% | 609.23K |
$4.00 | $2,436,924.00 | 1.76M |
Apr 26
| |||
Form 4
|
∞
| 1.15M |
$13.00 | $14,999,998.00 | 1.15M |
May 21
| |||
Form 4
| -100.00% | -553.25K |
—
|
—
|
0
|
Apr 17
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tracon Pharmaceuticals, Inc. (TCON) Snapshot price: $0.13925
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -83.47% | -384.13K |
$2.93 | -$1,127,379.08 | 76.05K |
Dec 5 - Dec 9
| |||
Form 4/A
|
—
|
0
|
$1.17 | -$346.08 | 4.6M |
Nov 29
| |||
Form 4
| +0.19% | 8.65K |
$1.17 | $10,122.84 | 4.6M |
Nov 29
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
EKSO BIONICS HOLDINGS, INC. (EKSO) Snapshot price: $1.21
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +286.72% | 7.38K |
—
|
—
| 9.96K |
Jul 23
| |||
Form 4
| -43.43% | -8.92M |
—
|
—
| 11.62M |
Mar 2
| |||
Form 4
| +101.39% | 19.45K |
$0.45 | $8,750.25 | 38.62K |
Jan 16
| |||
Form 4
|
∞
| 19.18K |
$1.79 | $34,330.41 | 19.18K |
Aug 3
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||